Characteristics of the MCL and CLL cohorts
| Cohort characteristics . | MCL . | CLL . | ||
|---|---|---|---|---|
| n . | % . | n . | % . | |
| Median age, y | 65 | 65 | ||
| Range | 37-90 | 35-81 | ||
| Ki67 high (> 0.4) | 13/39 | 33.3 | ||
| Blastoid morphology | 7/59 | 11.9 | ||
| Unmutated IGHV | 43/58 | 74.1 | 32/54 | 59.3 |
| TP53 mutation | 16/68 | 23.5 | 20/54 | 37.0 |
| Deletion 9p21 | 25/62 | 40.3 | ||
| Deletion 11q22-q23 | 25/62 | 40.3 | 11/55 | 20 |
| Deletion 13q14 | 35/62 | 56.5 | 21/55 | 38.2 |
| Deletion 17p13 | 12/58 | 20.7 | 12/55 | 21.8 |
| No aberration | 1/62 | 1.6 | 5/55 | 9.1 |
| Cohort characteristics . | MCL . | CLL . | ||
|---|---|---|---|---|
| n . | % . | n . | % . | |
| Median age, y | 65 | 65 | ||
| Range | 37-90 | 35-81 | ||
| Ki67 high (> 0.4) | 13/39 | 33.3 | ||
| Blastoid morphology | 7/59 | 11.9 | ||
| Unmutated IGHV | 43/58 | 74.1 | 32/54 | 59.3 |
| TP53 mutation | 16/68 | 23.5 | 20/54 | 37.0 |
| Deletion 9p21 | 25/62 | 40.3 | ||
| Deletion 11q22-q23 | 25/62 | 40.3 | 11/55 | 20 |
| Deletion 13q14 | 35/62 | 56.5 | 21/55 | 38.2 |
| Deletion 17p13 | 12/58 | 20.7 | 12/55 | 21.8 |
| No aberration | 1/62 | 1.6 | 5/55 | 9.1 |